Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death

Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death

Bibliographic Details
Main Authors: Williams, Mark D, Janes, Jonathan M, Nelson, David R
Format: Online
Language:English
Published: BioMed Central 2006
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751048/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751048/

Similar Items